Article

Genetic ablation of NADPH oxidase enhances susceptibility to cigarette smoke-induced lung inflammation and emphysema in mice. Am J Pathol

Department of Environmental Medicine, Lung Biology and Disease Program, University of Rochester Medical Center, Box 850, 601 Elmwood Ave., Rochester, NY 14642, USA.
American Journal Of Pathology (Impact Factor: 4.6). 06/2008; 172(5):1222-37. DOI: 10.2353/ajpath.2008.070765
Source: PubMed

ABSTRACT Cigarette smoke (CS) induces recruitment of inflammatory cells in the lungs leading to the generation of reactive oxygen species (ROS), which are involved in lung inflammation and injury. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is a multimeric system that is responsible for ROS production in mammalian cells. We hypothesized that NADPH oxidase-derived ROS play an important role in lung inflammation and injury and that targeted ablation of components of NADPH oxidase (p47(phox) and gp91(phox)) would protect lungs against the detrimental effects of CS. To test this hypothesis, we exposed p47(phox-/-) and gp91(phox-/-) mice to CS and examined inflammatory response and injury in the lung. Surprisingly, although CS-induced ROS production was decreased in the lungs of p47(phox-/-) and gp91(phox-/-) mice compared with wild-type mice, the inflammatory response was significantly increased and was accompanied by development of distal airspace enlargement and alveolar destruction. This pathological abnormality was associated with enhanced activation of the TLR4-nuclear factor-kappaB pathway in response to CS exposure in p47(phox-/-) and gp91(phox-/-) mice. This phenomenon was confirmed by in vitro studies in which treatment of peritoneal macrophages with a nuclear factor-kappaB inhibitor reversed the CS-induced release of proinflammatory mediators. Thus, these data suggest that genetic ablation of components of NADPH oxidase enhances susceptibility to the proinflammatory effects of CS leading to airspace enlargement and alveolar damage.

Download full-text

Full-text

Available from: Saravanan Rajendrasozhan, Aug 22, 2015
1 Follower
 · 
92 Views
  • Source
    • "Furthermore, a low i.p. dose of LPS [5 lg/g body weight (bw)], equally induced pulmonary NF-jB activation in p47 phox-/-and WT mice, however, 20 lg/g bw, i.p. dose of LPS-mediated NF-jB activation was lower in p47 phox-/mice (Koay et al. 2001). In support of these observations, another report showed that susceptibility to cigarette smokeinduced lung inflammation and emphysema was significantly enhanced in mice genetically ablated of NADPH oxidase (p47 phox and gp91 phox ) (Yao et al. 2008). These contradictory findings clearly state that low dose of LPS does not induce NF-jB activation via ROS, or that mice deficient in NADPH oxidase components can compensate this defect by either xanthine oxidase (Faggioni et al. 1994; Nakai et al. 2006) or mitochondria-mediated ROS production (Boczkowski et al. 1999; Ritter et al. 2003). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Rel/NF-κB transcription factors play a key role in modulating the response of immunoregulatory genes including cytokines and chemokines, cell adhesion molecules, acute phase proteins, and anti-microbial peptides. Furthermore, an array of genes important for angiogenesis, tumor invasion and metastasis is also regulated by nuclear factor-κB (NF-κB). Close association of NF-κB with inflammation and tumorigenesis makes it an attractive target for basic research as well as for pharmaceutical industries. Studies involving various animal and cellular models have revealed the importance of NF-κB in pathobiology of lung diseases. This review (a) describes structures, activities, and regulation of NF-κB family members; (b) provides information which implicates NF-κB in pathogenesis of pulmonary inflammation and cancer; and (c) discusses information about available synthetic and natural compounds which target NF-κB or specific components of NF-κB signal transduction pathway and which may provide the foundation for development of effective therapy for lung inflammation and bronchogenic carcinomas.
    Archivum Immunologiae et Therapiae Experimentalis 07/2011; 59(5):335-51. DOI:10.1007/s00005-011-0136-z · 2.82 Impact Factor
  • Source
    • "Med. (2011), doi:10.1016/j.freeradbiomed.2011.02.027 exposure [19]. Consistent with these data, we have recently shown that genetic deficiency of NADPH oxidase does not diminish, but rather enhances, LPS-induced acute lung inflammatory responses [21]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In vitro and limited in vivo evidence suggests that reactive oxygen species derived from NADPH oxidases (NOX-ROS) play an important role in inflammatory responses by enhancing the activity of redox-sensitive cell signaling pathways and transcription factors. Here, we investigated the role of NOX-ROS in TNFα-induced acute inflammatory responses in vivo, using mice deficient in the gp91(phox) (NOX2) or p47(phox) subunits of NADPH oxidase. Age- and body weight-matched C57BL/6J wild-type (WT) and gp91(phox) or p47(phox) knockout mice were injected intraperitoneally with 50 μg TNFα/kg bw or saline vehicle control and sacrificed at various time points up to 24 h. Compared to WT mice, gp91(phox -/-) mice exhibited significantly diminished (P<0.05) TNFα-induced acute inflammatory responses in the lungs but not other tissues, including heart, liver, and kidney, as evidenced by decreased activation of the redox-sensitive transcription factor NF-κB, and decreased gene expression of interleukin (IL)-1β, IL-6, TNFα, E-selectin, and other cellular adhesion molecules. Similar results were observed in p47(phox -/-) mice. Interestingly, decreased lung inflammation in knockout mice was accompanied by increased leukocyte infiltration into the lungs compared to other tissues. Our data suggest that phagocytic NOX-ROS signaling plays a critical role in promoting TNFα-induced, NF-κB-dependent acute inflammatory responses and tissue injury specifically in the lungs, which is effected by preferential leukocyte infiltration.
    Free Radical Biology and Medicine 03/2011; 50(11):1517-25. DOI:10.1016/j.freeradbiomed.2011.02.027 · 5.71 Impact Factor
  • Source
    • "In particular, acetylation of lysine 310 is important in pro-inflammatory gene transcription. Previously, we have shown that cigarette smoke exposure induced the inflammatory cells influx which was associated with increased levels of various NF-κB-dependent pro-inflammatory mediators in lungs, and IKK-β inhibitors attenuated cigarette smoke extract-induced NF-κB-dependent proinflammatory mediators release from peritoneal macrophages and monocyte-macrophage MonoMac6 cells (Yang et al., 2006;Yao et al., 2008b). The alternative or noncanonical pathway requires the NF-κB-inducing kinase (NIK), which cooperates with IKK-α to induce the processing of the p100 C-terminus (termed IκBδ), which results in the nuclear translocation of p52:RelB (Senftleben et al., 2001;Yin et al., 2001;Xiao et al., 2004). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chronic obstructive pulmonary disease (COPD) is a global health problem. The current therapies for COPD are poorly effective and the mainstays of pharmacotherapy are bronchodilators. A better understanding of the pathobiology of COPD is critical for the development of novel therapies. In the present review, we have discussed the roles of oxidative/aldehyde stress, inflammation/immunity, and chromatin remodeling in the pathogenesis of COPD. An imbalance of oxidants/antioxidants caused by cigarette smoke and other pollutants/biomass fuels plays an important role in the pathogenesis of COPD by regulating redox-sensitive transcription factors (e.g., NF-κB), autophagy and unfolded protein response leading to chronic lung inflammatory response. Cigarette smoke also activates canonical/alternative NF-κB pathways and their upstream kinases leading to sustained inflammatory response in lungs. Recently, epigenetic regulation has been shown to be critical for the development of COPD because the expression/activity of enzymes that regulate these epigenetic modifications have been reported to be abnormal in airways of COPD patients. Hence, the significant advances made in understanding the pathophysiology of COPD as described herein will identify novel therapeutic targets for intervention in COPD.
    Toxicology and Applied Pharmacology 02/2011; 254(2):72-85. DOI:10.1016/j.taap.2009.10.022 · 3.63 Impact Factor
Show more